HomeFileCoronary disease

Coronary disease

Zwolle Score: Can a Risk Score Decide Where STEACS Patients Should Stay?

The mortality of ST-segment elevation acute coronary syndromes (STEACS) has decreased thanks to improved reperfusion times (fibrinolysis...

Is Epinephrine Superior to Adenosine in No-REFLOW?

In patients with acute coronary syndrome, no-reflow prevalence is 32%. Different drugs—such as adenosine, verapamil, nitroprusside, or...

Acute Coronary Syndrome: What Is Safer, Antiaggregant Monotherapy or De-Escalation?

For several years it has been shown that 12-month dual antiplatelet therapy (DAPT) is mandatory for patients...

IVUS in Acute Coronary Syndrome: A New Requirement?

The use of intravascular ultrasound (IVUS) has seen exponential growth across registries over the years, combined with...

10/03 | Masterclass Medtronic-SOLACI with Gregg Stone: Complex PCI Scenario

We invite you to take part in a new Medtronic-SOLACI masterclass with Dr. Gregg Stone (USA) and...

Bypass Grafting and Native Coronary Artery Disease Activity

Positron emission tomography (PET) with F sodium fluoride (F-NaF) allows for the assessment of microcalcification activity (MA)...

Webinar SOLACI-CACI@MicroPort: Conquering Complex Coronary Artery Lesions

We invite you to participate in a new educational activity of high scientific level organized by SOLACI...